Rare Disease Treatment, HYFTOR® (sirolimus topical gel) 0.2% Coverage Expanded by Medicaid, Including in Key U.S. States ...Middle East

BETHESDA, Md., March 14, 2023 /PRNewswire/ -- HYFTOR® (sirolimus topical gel) 0.2%, indicated for the treatment of facial angiofibroma associated with tuberous sclerosis complex (TSC) in adults and pediatric patients 6 years of age and older, is now covered by Medicare in Texas, Florida,...

Hence then, the article about rare disease treatment hyftor sirolimus topical gel 0 2 coverage expanded by medicaid including in key u s states was published today ( Tuesday 14/03/2023 - 03:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Rare Disease Treatment, HYFTOR® (sirolimus topical gel) 0.2% Coverage Expanded by Medicaid, Including in Key U.S. States )

Also on site :

• Musk mulling mega-mergers – Bloomberg
• Can Cell Phones Stop ICE?
• Kurdish-led SDF agrees integration with Syrian government forces